Tang’s Con­cen­tra faces off with Fore­site, Or­biMed in buy­out bat­tle for strug­gling biotech The­seus

Cal­i­for­nia in­vest­ment group Tang Cap­i­tal Man­age­ment is con­tin­u­ing its streak of buy­out of­fers for strug­gling biotechs, this time eye­ing The­seus Phar­ma­ceu­ti­cals. How­ev­er, an al­ter­na­tive propo­si­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER